Prozone Realty per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹0.75₹0.70−₹2.49₹0.30₹1.66
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹0.75₹0.70−₹2.49₹0.30₹1.66
₹149.53₹149.53₹30.65₹33.38₹33.55
₹56.43₹63.96₹11.71₹12.09₹11.35
—₹25.19₹2.60₹3.95₹5.37
₹23.56₹23.56₹2.10₹3.91₹5.20
3.13.115.315.315.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PROZONER₹50.80

Prozone Realty Limited

· Real Estate
₹ CrorePeersVASCONEQMODISCCCLELDEHSGARIHANTSURAJESTNILASPACESUNITECHMcap ₹155 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS1.660.30-2.490.700.75
Diluted EPS1.660.30-2.490.700.75
Book Value per Share33.5533.3830.65149.53149.53
Revenue per Share11.3512.0911.7163.9656.43
Cash Flow per Share5.373.952.6025.19—
Free Cash Flow per Share5.203.912.1023.5623.56
Shares Outstanding (cr)15.315.315.33.13.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.